Abstract
Abstract
Introduction
Pooled procurement can be seen as a collaboration initiative of buyers. Such mechanisms have received increased attention during the Covid-19 pandemic to improve access to affordable and quality-assured health commodities. The structural form of pooled procurement mechanisms ranges from a third-party organization that procures on behalf of its buyers to a buyer’s owned mechanism in which buyers operate more collaboratively. However, little is known about how these types of pooled procurement mechanisms differ in terms of characteristics, implementation and developmental process. To fill this gap, we compared four pooled procurement mechanisms. Two buyer’s owned mechanisms: the Organisation of the Eastern Caribbean States (OECS) and the Pacific Island Countries (PIC). And two third-party mechanisms: the Global Drug Facility (GDF) and the Asthma Drug Facility (ADF).
Methods
For this qualitative study, we used a multiple case-study design. The cases were purposefully selected, based on a most-similar case study design. We used the Pooled Procurement Guidance to collect data on individual cases and compared our findings between the case studies. For our analysis, we drew upon peer-reviewed academic articles, grey literature documents and 9 semi-structured interviews with procurement experts.
Results
Buyers within a buyer’s owned mechanisms differ in procurement systems, financing structures, product needs and regulatory and legal frameworks. Therefore, buyers within such mechanisms require relative alignment on motivations, goals and operations of the mechanism. Our study showed that buyers’ relative homogeneity of characteristics and their perceived urgency of the problems was particularly relevant for achieving that alignment.
Third-party organization mechanisms require less alignment and consensus-building between buyers. To participate, buyers need to align with the operations of the third-party organization, instead of other buyers. Elements that were essential for the successful implementation and operation of such mechanisms included the procurement secretariat’s ability to create local and global awareness around the problem, to induce political will to act upon the problem, to mobilize sufficient funding and to attract qualified staff.
Conclusion
To successfully sustain pooled procurement mechanisms over time, key actors should drive the mechanism through continuous and reflexive work on stakeholder engagement, mobilization of funding and alignment of interests and needs.
Funder
United States Pharmacopeia (USP) Quality Institute
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference73 articles.
1. Covax COVAX. Key Learnings for Future Pandemic Preparedness and Response. 2022. Available from: https://cepi.net/wp-content/uploads/2022/09/COVAX_Key-Learnings-for-Future-PPR_Sept-2022_FINAL_Updated-artwork.pdf.
2. Suneja K. Exporters line up for restricted Active Pharmaceutical Ingredients licence. 2020; Available from: https://economictimes.indiatimes.com/news/economy/policy/exporters-line-up-for-restricted-active-pharmaceutical-ingredients-licence/articleshow/74642481.cms?from=mdr.
3. Kuchler H. US report reveals hospitals’ struggle with shortages. Financial Times. 2020; Available from: https://www.ft.com/content/6cf8b7a9-ed3b-4818-b8d1-823ae663a692.
4. INTERPOL. Global operation sees a rise in fake medical products related to COVID-19. 2020. Available from: https://www.interpol.int/News-and-Events/News/2020/Global-operation-sees-a-rise-in-fake-medical-products-related-to-COVID-19.
5. Kuchler H. US drugmaker doubled price on potential coronavirus treatment. Financial Times. 2020; Available from: https://www.ft.com/content/b7a21a16-6a1f-11ea-800d-da70cff6e4d3.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献